Cellular processing of platinum anticancer drugs

p53 Mutations in Human Cancers

Hollstein, M., Sidransky, D., Vogelstein, B., & Harris, C. C. (1991) · Science · doi:10.1126/science.1905840 · Cited by 8,018 · see citing works

Cytochrome c and dATP-Dependent Formation of Apaf-1/Caspase-9 Complex Initiates an Apoptotic Protease Cascade

Li, P., Nijhawan, D., Budihardjo, I., Srinivasula, S. M., Ahmad, M., Alnemri, E. S., & Wang, X. (1997) · Cell · doi:10.1016/s0092-8674(00)80434-1 · Cited by 7,289 · see citing works

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

Hanahan, D., & Folkman, J. (1996) · Cell · doi:10.1016/s0092-8674(00)80108-7 · Cited by 6,885 · see citing works

Signal transduction by the JNK group of MAP kinases

Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237 · see citing works

Release of chromatin protein HMGB1 by necrotic cells triggers inflammation

Scaffidi, P., Misteli, T., & Bianchi, M. E. (2002) · Nature · doi:10.1038/nature00858 · Cited by 4,221 · see citing works

Cellular survival: a play in three Akts

Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216 · see citing works

Structure, Recognition, and Processing of Cisplatin−DNA Adducts

Jamieson, E. R., & Lippard, S. J. (1999) · Chemical Reviews · doi:10.1021/cr980421n · Cited by 2,953 · see citing works

Cancer Treatment by Targeted Drug Delivery to Tumor Vasculature in a Mouse Model

Arap, W., Pasqualini, R., & Ruoslahti, E. I. (1998) · Science · doi:10.1126/science.279.5349.377 · Cited by 2,040 · see citing works

The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase

Franke, T. F., Yang, S., Chan, T. O., Datta, K., Kazlauskas, A., Morrison, D. K., Kaplan, D. R., & Tsichlis, P. N. (1995) · Cell · doi:10.1016/0092-8674(95)90534-0 · Cited by 2,006 · see citing works

Current Status of Platinum-Based Antitumor Drugs

Wong, E., & Giandomenico, C. M. (1999) · Chemical Reviews · doi:10.1021/cr980420v · Cited by 1,802 · see citing works

Chk1 is an essential kinase that is regulated by Atr and required for the G ₂ /M DNA damage checkpoint

Liu, Q., Guntuku, S., Cui, X.-S., Matsuoka, S., Cortez, D., Tamai, K., Luo, G., Carattini-Rivera, S., DeMayo, F., Bradley, A., et al. (2000) · Genes & Development · doi:10.1101/gad.14.12.1448 · Cited by 1,625 · see citing works

Mitogen-activated protein kinases in apoptosis regulation

Wada, T., & Penninger, J. M. (2004) · Oncogene · doi:10.1038/sj.onc.1207556 · Cited by 1,432 · see citing works

Mitotic and G ₂ Checkpoint Control: Regulation of 14-3-3 Protein Binding by Phosphorylation of Cdc25C on Serine-216

Peng, C.-Y., Graves, P. R., Thoma, R. S., Wu, Z., Shaw, A. S., & Piwnica-Worms, H. (1997) · Science · doi:10.1126/science.277.5331.1501 · Cited by 1,341 · see citing works

Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase

Matsuoka, S. (1998) · Science · doi:10.1126/science.282.5395.1893 · Cited by 1,322 · see citing works

Conservation of the Chk1 Checkpoint Pathway in Mammals: Linkage of DNA Damage to Cdk Regulation Through Cdc25

Sanchez, Y., Wong, C., Thoma, R. S., Richman, R., Wu, Z., Piwnica-Worms, H., & Elledge, S. J. (1997) · Science · doi:10.1126/science.277.5331.1497 · Cited by 1,320 · see citing works

DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall

Bohr, V (1985) · Cell · doi:10.1016/0092-8674(85)90150-3 · Cited by 1,237 · see citing works

Selective removal of transcription-blocking DNA damage from the transcribed strand of the mammalian DHFR gene

MELLON, I. (1987) · Cell · doi:10.1016/0092-8674(87)90151-6 · Cited by 1,228 · see citing works

p38 MAP kinases: key signalling molecules as therapeutic targets for inflammatory diseases

Kumar, S., Boehm, J. C., & Lee, J. C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1177 · Cited by 1,199 · see citing works

Autoactivation of Procaspase-9 by Apaf-1-Mediated Oligomerization

Srinivasula, S. M., Ahmad, M., Fernandes‐Alnemri, T., & Alnemri, E. S. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80095-7 · Cited by 1,119 · see citing works

Decision making by p53: life, death and cancer

Oren, M. (2003) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401183 · Cited by 1,063 · see citing works

Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals

Ishida, S., Lee, J., Thiele, D. J., & Herskowitz, I. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.162491399 · Cited by 927 · see citing works

The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage

Gong, J., Costanzo, A., Yang, H., Melino, G., Kaelin, W. G., Levrero, M., & Wang, J. Y. J. (1999) · Nature · doi:10.1038/21690 · Cited by 923 · see citing works

Xeroderma Pigmentosum Group C Protein Complex Is the Initiator of Global Genome Nucleotide Excision Repair

Sugasawa, K., Ng, J. M. Y., Masutani, C., Iwai, S., van der Spek, P. J., Eker, A. P. M., Hanaoka, F., Bootsma, D., & Hoeijmakers, J. H. J. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80132-x · Cited by 899 · see citing works

Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance

Fuertes, M. A., Alonso‐Moreno, C., & Pérez, J. M. (2003) · Chemical Reviews · doi:10.1021/cr020010d · Cited by 896 · see citing works

Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.

Kool, M., de Haas, M., Scheffer, G. L., Scheper, R. J., van Eijk, M. J., Juijn, J. A., Baas, F., & Borst, P. (1997) · PubMed · Cited by 882 · see citing works

The Role of c-Jun N-terminal Kinase (JNK) in Apoptosis Induced by Ultraviolet C and γ Radiation

Chen, Y.-R., Wang, X., Templeton, D., Davis, R. J., & Tan, T.-H. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.50.31929 · Cited by 867 · see citing works

Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis.

Pasqualini, R., Koivunen, E., Kain, R., Lahdenranta, J., Sakamoto, M., Stryhn, A., Ashmun, R., Shapiro, L., Arap, W., & Ruoslahti, E. I. (2000) · PubMed · Cited by 859 · see citing works

Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro

Matsuoka, S., Rotman, G., Ogawa, A., Shiloh, Y., Tamai, K., & Elledge, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190030497 · Cited by 830 · see citing works

Clinical development of platinum complexes in cancer therapy: an historical perspective and an update

Lebwohl, D., & Canetta, R. M. (1998) · European Journal of Cancer · doi:10.1016/s0959-8049(98)00224-x · Cited by 756 · see citing works

Akt Phosphorylates and Negatively Regulates Apoptosis Signal-Regulating Kinase 1

Kim, A. H., Khursigara, G., Sun, X., Franke, T. F., & Chao, M. V. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.3.893-901.2001 · Cited by 710 · see citing works

Requirement for ERK Activation in Cisplatin-induced Apoptosis

Wang, X., Martindale, J. L., & Holbrook, N. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004583200 · Cited by 678 · see citing works

Drug Resistance and ATP-Dependent Conjugate Transport Mediated by the Apical Multidrug Resistance Protein, MRP2, Permanently Expressed in Human and Canine Cells

Cui, Y., König, J., Buchholz, U., Spring, H., Leier, I., & KEPPLER, D. O. R. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)23190-4 · Cited by 674 · see citing works

Essential role of BETA2/NeuroD1 in development of the vestibular and auditory systemsPreprint

Liu, M., Pereira, F. A., Price, S. D., Chu, M.-J., Shope, C. D., Himes, D., Eatock, R. A., Brownell, W. E., Lysakowski, A., & Tsai, M. (2000) · Genes & Development · doi:10.1101/gad.840500 · Cited by 625 · see citing works

Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel

Rixe, O., Ortuzar, W. I., Alvarez, M. G., Parker, R., Reed, E., Paull, K. D., & Fojo, T. (1996) · Biochemical Pharmacology · doi:10.1016/s0006-2952(97)81490-6 · Cited by 615 · see citing works

Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53

Katayama, H. G., Sasai, K., Kawai, H., Yuan, Z.-M., Bondaruk, J. E., Suzuki, F., Fujii, S., Arlinghaus, R. B., Czerniak, B. A., & Sen, S. (2003) · Nature Genetics · doi:10.1038/ng1279 · Cited by 586 · see citing works

Expression of the <i>p48</i> xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair

Hwang, B. J., Ford, J. M., Hanawalt, P. C., & Chu, G. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.424 · Cited by 581 · see citing works

Is Cisplatin-Induced Cell Death Always Produced by Apoptosis?

González, V. M., Fuertes, M. A., Alonso‐Moreno, C., & Pérez, J. M. (2001) · Molecular Pharmacology · doi:10.1124/mol.59.4.657 · Cited by 579 · see citing works

Nuclear localization of Cdc25 is regulated by DNA damage and a 14-3-3 protein

Lopez‐Girona, A., Furnari, B. A., Mondésert, O., & Russell, P. R. (1999) · Nature · doi:10.1038/16488 · Cited by 574 · see citing works

p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage

Yuan, Z.-M., Shioya, H., Ishiko, T., Sun, X., Gu, J., Huang, Y., Lu, H., Kharbanda, S. M., Weichselbaum, R. W., & Kufe, D. W. (1999) · Nature · doi:10.1038/21704 · Cited by 574 · see citing works

Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks

Pommier, Y. G., Sordet, O., Antony, S., Hayward, R. L., & Kohn, K. W. (2004) · Oncogene · doi:10.1038/sj.onc.1207515 · Cited by 559 · see citing works

The chromatin-specific transcription elongation factor FACT comprises human SPT16 and SSRP1 proteins

Orphanides, G., Wu, W.-H., Lane, W. S., Hampsey, M., & Reinberg, D. (1999) · Nature · doi:10.1038/22350 · Cited by 554 · see citing works

p53 modulation of TFIIH–associated nucleotide excision repair activity

Wang, X. W., Yeh, H., Schaeffer, L., Roy, R., Moncollin, V., Egly, J., Wang, Z., Friedberg, E. C., Evans, M. K., Taffe, B. G., et al. (1995) · Nature Genetics · doi:10.1038/ng0695-188 · Cited by 550 · see citing works

Interaction of c-Abl and p73α and their collaboration to induce apoptosis

Agami, R., Blandino, G., Oren, M., & Shaul, Y. (1999) · Nature · doi:10.1038/21697 · Cited by 544 · see citing works

Cdc25 Mitotic Inducer Targeted by Chk1 DNA Damage Checkpoint Kinase

Furnari, B. A., Rhind, N., & Russell, P. R. (1997) · Science · doi:10.1126/science.277.5331.1495 · Cited by 542 · see citing works

Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion

Hamilton, T. C., Winker, M. A., Louie, K. G., et al. (1985) · Biochemical Pharmacology · doi:10.1016/0006-2952(85)90551-9 · Cited by 542 · see citing works

MSK2 and MSK1 mediate the mitogen‐ and stress‐induced phosphorylation of histone H3 and HMG‐14

Soloaga, A., Thomson, S., Wiggin, G. R., Rampersaud, N., Dyson, M. H., Hazzalin, C. A., Mahadevan, L. C., & Arthur, J. S. C. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg273 · Cited by 508 · see citing works

Functions of poly(ADP-ribose) polymerase (PARP) in DNA repair, genomic integrity and cell death

Herceg, Z., & Wang, Z. (2001) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(01)00111-7 · Cited by 489 · see citing works

Transcriptional regulation by the MAP kinase signaling cascades

Yang, S., Sharrocks, A. D., & Whitmarsh, A. J. (2003) · Gene · doi:10.1016/s0378-1119(03)00816-3 · Cited by 489 · see citing works

Activation of the c-Abl tyrosine kinase in the stress response to DMA-damaging agents

Kharbanda, S. M., Ren, R., Pandey, P., Shafman, T. D., Feller, S. M., Weichselbaum, R. R., & Kufe, D. W. (1995) · Nature · doi:10.1038/376785a0 · Cited by 484 · see citing works

Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA.

Kim, M. S., Blake, M., Baek, J. H., Kohlhagen, G., Pommier, Y. G., & Carrier, F. (2003) · PubMed · Cited by 464 · see citing works

Cellular and molecular pharmacology of oxaliplatin.

Raymond, É., Faivre, S. J., Chaney, S. G., WOYNAROWSKI, J. M., & Cvitkovic, E. (2002) · PubMed · Cited by 463 · see citing works

Mechanisms of death induced by cisplatin in proximal tubular epithelial cells: apoptosis vs. necrosis

Lieberthal, W., Triaca, V., & Levine, J. S. (1996) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.1996.270.4.f700 · Cited by 452 · see citing works

The nucleosomal response associated with immediate‐early gene induction is mediated via alternative MAP kinase cascades: MSK1 as a potential histone H3/HMG‐14 kinase

Thomson, S., Clayton, A. L., Hazzalin, C. A., Rose, S., Barratt, M. J., & Mahadevan, L. C. (1999) · The EMBO Journal · doi:10.1093/emboj/18.17.4779 · Cited by 451 · see citing works

Subpathways of nucleotide excision repair and their regulation

Hanawalt, P. C. (2002) · Oncogene · doi:10.1038/sj.onc.1206096 · Cited by 447 · see citing works

Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy.

Dabholkar, M., Vionnet, J. A., Bostick-Bruton, F., Yu, J. J., & Reed, E. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117388 · Cited by 446 · see citing works

The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat

Zanke, B. W., Boudreau, K., Rubie, E. A., Winnett, E., Tibbles, L. A., Zon, L. I., Kyriakis, J. M., Liu, F., & Woodgett, J. R. (1996) · Current Biology · doi:10.1016/s0960-9822(02)00547-x · Cited by 444 · see citing works

p53-Mediated DNA Repair Responses to UV Radiation: Studies of Mouse Cells Lacking p53, p21, and/orgadd45 Genes

Smith, M. L., Ford, J. M., Hollander, M. C., Bortnick, R. A., Amundson, S. A., Seo, Y. R., Deng, C., Hanawalt, P. C., & Fornace, A. J. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.10.3705-3714.2000 · Cited by 432 · see citing works

DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis

Dasika, G. K., Lin, S.-C. J., Zhao, S., Sung, P., Tomkinson, A., & Lee, E. Y.-H. P. (1999) · Oncogene · doi:10.1038/sj.onc.1203283 · Cited by 427 · see citing works

BRCA1 functions as a differential modulator of chemotherapy-induced apoptosis.

Quinn, J. E., Kennedy, R. D., Mullan, P. B., Gilmore, P. M., Carty, M., Johnston, P. G., & Harkin, D. P. (2003) · PubMed · Cited by 401 · see citing works

Recognition and processing of cisplatin- and oxaliplatin-DNA adducts

Chaney, S. G., Campbell, S. L., Bassett, E., & Wu, Y. (2004) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.08.008 · Cited by 395 · see citing works

Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems.

Perego, P., Giarola, M., Righetti, S. C., Supino, R., Caserini, C., Delia, D., Pierotti, M. A., Miyashita, T., Reed, J. C., & Zunino, F. (1996) · PubMed · Cited by 386 · see citing works

Sustained Activation of JNK/p38 MAPK Pathways in Response to Cisplatin Leads to Fas Ligand Induction and Cell Death in Ovarian Carcinoma Cells

Mansouri, A., Ridgway, L. D., Korapati, A. L., Zhang, Q. C., Tian, L., Wang, Y., Siddik, Z. H., Mills, G. B., & Claret, F. X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m208134200 · Cited by 377 · see citing works

Inhibition of DNA replication factor RPA by p53

Dutta, A., Ruppert, J. M., Aster, J. C., & Winchester, E. (1993) · Nature · doi:10.1038/365079a0 · Cited by 375 · see citing works

The eukaryotic nucleotide excision repair pathway

Costa, R. (2003) · Biochimie · doi:10.1016/j.biochi.2003.10.017 · Cited by 373 · see citing works

Biochemical basis for cisplatin and 5-fluorouracil synergism in human ovarian carcinoma cells.

Scanlon, K. J., Newman, E. M., Lu, Y., et al. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.23.8923 · Cited by 369 · see citing works

Cisplatin-Induced Renal Cell Apoptosis: Caspase 3-Dependent and -Independent Pathways

Cummings, B. S., & Schnellmann, R. G. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.302.1.8 · Cited by 358 · see citing works

Recognition of cisplatin adducts by cellular proteins

Kartalou, M., & Essigmann, J. M. (2001) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(01)00142-7 · Cited by 350 · see citing works

A role for methylation of the hMLH1 promoter in loss of hMLH1 expression and drug resistance in ovarian cancer

Strathdee, G. R., Mackean, M., Illand, M., & Brown, R. E. (1999) · Oncogene · doi:10.1038/sj.onc.1202540 · Cited by 350 · see citing works

Transcription-coupled nucleotide excision repair as a determinant of cisplatin sensitivity of human cells.

Furuta, T., Ueda, T., Aune, G. J., Sarasin, A. R., Kraemer, K. H., & Pommier, Y. G. (2002) · PubMed · Cited by 349 · see citing works

HMG-domain proteins specifically inhibit the repair of the major DNA adduct of the anticancer drug cisplatin by human excision nuclease.

Huang, J. C., Zamble, D. B., Reardon, J. T., Lippard, S. J., & Sancar, A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.22.10394 · Cited by 347 · see citing works

Li-Fraumeni syndrome fibroblasts homozygous for p53 mutations are deficient in global DNA repair but exhibit normal transcription-coupled repair and enhanced UV resistance.

Ford, J. M., & Hanawalt, P. C. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.19.8876 · Cited by 343 · see citing works

XIAP regulates Akt activity and caspase-3-dependent cleavage during cisplatin-induced apoptosis in human ovarian epithelial cancer cells.

Asselin, É., Mills, G. B., & Tsang, B. K. (2001) · PubMed · Cited by 336 · see citing works

p38 MAP kinase: a convergence point in cancer therapy

Olson, J. M., & Hallahan, A. R. (2004) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2004.01.007 · Cited by 335 · see citing works

Repair of Cisplatin−DNA Adducts by the Mammalian Excision Nuclease

Zamble, D. B., Mu, D., Reardon, J. T., Sancar, A., & Lippard, S. J. (1996) · Biochemistry · doi:10.1021/bi960453+ · Cited by 334 · see citing works

Platinum‐based anticancer agents: Innovative design strategies and biological perspectives

Ho, Y., Au‐Yeung, S. C. F., & To, K. K. W. (2003) · Medicinal Research Reviews · doi:10.1002/med.10038 · Cited by 329 · see citing works

Copper-transporting P-type adenosine triphosphatase (ATP7B) is associated with cisplatin resistance.

Komatsu, M., Sumizawa, T., Mutoh, M., Chen, Z., Terada, K., Furukawa, T., Yang, X., Gao, H., Miura, N., Sugiyama, T., et al. (2000) · PubMed · Cited by 328 · see citing works

p53 and DNA damage-inducible expression of the xeroderma pigmentosum group C gene

Adimoolam, S., & Ford, J. M. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.202485699 · Cited by 321 · see citing works

High mobility group protein-1 (HMG-1) is a unique activator of p53Preprint

Jayaraman, L., Moorthy, N. C., Murthy, K. G. K., Manley, J. L., Bustin, M., & Prives, C. L. (1998) · Genes & Development · doi:10.1101/gad.12.4.462 · Cited by 319 · see citing works

Defective repair of cisplatin-induced DNA damage caused by reduced XPA protein in testicular germ cell tumours

Köberle, B., Masters, J. R., Hartley, J. A., & Wood, R. D. (1999) · Current Biology · doi:10.1016/s0960-9822(99)80118-3 · Cited by 298 · see citing works

The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2.

Eliopoulos, A. G., Kerr, R. S., Herod, J., Hodgkins, L., Krajewski, S., Reed, J. C., & Young, L. S. (1995) · PubMed · Cited by 296 · see citing works

Cisplatin and Adriamycin Resistance Are Associated with MutLα and Mismatch Repair Deficiency in an Ovarian Tumor Cell Line

Drummond, J. T., Anthoney, A., Brown, R. E., & Modrich, P. L. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.33.19645 · Cited by 295 · see citing works

BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum(II).

Husain, A., He, G., Venkatraman, E. S., & Spriggs, D. R. (1998) · PubMed · Cited by 291 · see citing works

Acquisition of resistance to cisplatin is accompanied by changes in the cellular pharmacology of copper.

Katano, K., Kondo, A., Safaei, R., Holzer, A. K., Samimi, G., Mishima, M., Kuo, Y., Rochdi, M., & Howell, S. B. (2002) · PubMed · Cited by 290 · see citing works

Tracking FACT and the RNA Polymerase II Elongation Complex Through Chromatin in Vivo

Saunders, A., Werner, J. K., Andrulis, E. D., Nakayama, T. W., Hirose, S., Reinberg, D., & Lis, J. T. (2003) · Science · doi:10.1126/science.1085712 · Cited by 289 · see citing works

Effect of Extracellular Signal-regulated Kinase on p53 Accumulation in Response to Cisplatin

Persons, D. L., Yazlovitskaya, E. M., & Pelling, J. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004267200 · Cited by 288 · see citing works

Regulation of cell death by the Abl tyrosine kinase

Wang, J. Y. J. (2000) · Oncogene · doi:10.1038/sj.onc.1203878 · Cited by 278 · see citing works

Synthesis, Characterization, and Cytotoxicity of a Series of Estrogen-Tethered Platinum(IV) Complexes

Barnes, K. R., Kutikov, A., & Lippard, S. J. (2004) · Chemistry & Biology · doi:10.1016/j.chembiol.2004.03.024 · Cited by 262 · see citing works

Stimulation of V(D)J cleavage by high mobility group proteins

van Gent, D. C., Hiom, K. J., Paull, T. T., et al. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2665 · Cited by 261 · see citing works

Preclinical studies identifying carboplatin as a viable cisplatin alternative

Harrap, K. R. (1985) · Cancer Treatment Reviews · doi:10.1016/0305-7372(85)90015-5 · Cited by 259 · see citing works

BRCA1 induces DNA damage recognition factors and enhances nucleotide excision repair

Hartman, A., & Ford, J. (2002) · Nature Genetics · doi:10.1038/ng953 · Cited by 259 · see citing works

The DNA chaperone HMGB1 facilitates ACF/CHRAC‐dependent nucleosome sliding

Bonaldi, T., Längst, G., Strohner, R., Becker, P. B., & Bianchi, M. E. (2002) · The EMBO Journal · doi:10.1093/emboj/cdf692 · Cited by 254 · see citing works

Isolation and characterization of human cDNA clones encoding a high mobility group box protein that recognizes structural distortions to DNA caused by binding of the anticancer agent cisplatin.

BRUHN, S. L., Pil, P. M., Essigmann, J. M., et al. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2307 · Cited by 251 · see citing works

A canalicular multispecific organic anion transporter (cMOAT) antisense cDNA enhances drug sensitivity in human hepatic cancer cells.

Koike, K., Kawabe, T., Tanaka, T., Toh, S., Uchiumi, T., Wada, M., Akiyama, S. I., Ono, M., & Kuwano, M. (1997) · PubMed · Cited by 249 · see citing works

Carboxylation of Kinetically Inert Platinum(IV) Hydroxy Complexes. An Entr.acte.ee into Orally Active Platinum(IV) Antitumor Agents

Giandomenico, C. M., Abrams, M. J., Murrer, B. A., et al. (1995) · Inorganic Chemistry · doi:10.1021/ic00109a004 · Cited by 248 · see citing works

Role for ATM in DNA damage-induced phosphorylation of BRCA1.

Gatei, M. H., Scott, S. P., Filippovitch, I., Soronika, N., Lavin, M. F., Weber, B. L., & Khanna, K. K. (2000) · PubMed · Cited by 247 · see citing works

The Copper Influx Transporter Human Copper Transport Protein 1 Regulates the Uptake of Cisplatin in Human Ovarian Carcinoma Cells

Holzer, A. K., Samimi, G., Katano, K., et al. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.001198 · Cited by 247 · see citing works

Cisplatin-induced apoptosis proceeds by caspase-3-dependent and -independent pathways in cisplatin-resistant and -sensitive human ovarian cancer cell lines.

Henkels, K. M., & Turchi, J. J. (1999) · PubMed · Cited by 241 · see citing works

Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin

Division, P. (1992) · Lung Cancer · doi:10.1016/0169-5002(92)90185-m · Cited by 238 · see citing works

Cisplatin-induced activation of mitogen-activated protein kinases in ovarian carcinoma cells: inhibition of extracellular signal-regulated kinase activity increases sensitivity to cisplatin.

Persons, D. L., Yazlovitskaya, E. M., Cui, W., & Pelling, J. C. (1999) · PubMed · Cited by 237 · see citing works

Cisplatin induces a persistent activation of JNK that is related to cell death

Sánchez‐Pérez, I., Murguía, J. R., & Perona, R. (1998) · Oncogene · doi:10.1038/sj.onc.1201578 · Cited by 236 · see citing works

Multiple mechanisms of resistance to cis-diamminedichloroplatinum(II) in murine leukemia L1210 cells.

Richon, V. M., Schulte, N. A., & Eastman, A. R. (1987) · PubMed · Cited by 231 · see citing works

The Jun Kinase/Stress-activated Protein Kinase Pathway Functions to Regulate DNA Repair and Inhibition of the Pathway Sensitizes Tumor Cells to Cisplatin

Potapova, O., Haghighi, A. P., Bost, F., Liu, C., Birrer, M. J., Gjerset, R. A., & Mercola, D. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.22.14041 · Cited by 229 · see citing works

Influence of cis-diamminedichloroplatinum(II) on DNA synthesis and cell cycle progression in excision repair proficient and deficient Chinese hamster ovary cells.

Sorenson, C. M., & Eastman, A. R. (1988) · PubMed · Cited by 226 · see citing works

Reduced levels of XPA, ERCC1 and XPF DNA repair proteins in testis tumor cell lines

Welsh, C., Day, R., McGurk, C. J., Masters, J. R., Wood, R. D., & Köberle, B. (2004) · International Journal of Cancer · doi:10.1002/ijc.20134 · Cited by 215 · see citing works

Platinum-based chemotherapy in metastatic breast cancer: current status

Decatris, M. P., Sundar, S., & O'Byrne, K. J. (2003) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(03)00139-7 · Cited by 212 · see citing works

Inhibition of NFκB Increases the Efficacy of Cisplatin in in Vitro and in Vivo Ovarian Cancer Models

Mabuchi, S., Ohmichi, M., Nishio, Y., Hayasaka, T., Kimura, A., Ohta, T., Saito, M., Kawagoe, J., Takahashi, K., Yada-Hashimoto, N., et al. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313709200 · Cited by 210 · see citing works

Steroid hormones induce HMG1 overexpression and sensitize breast cancer cells to cisplatin and carboplatin

He, Q., Liang, C. H., & Lippard, S. J. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.100108697 · Cited by 208 · see citing works

Mini-review: discovery and development of platinum complexes designed to circumvent cisplatin resistance

Kèlland, L. R., Sharp, S. Y., O’Neill, C. F., Raynaud, F. I., Beale, P. J., & Judson, I. R. (1999) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(99)00141-5 · Cited by 206 · see citing works

In vivo effects of cis- and trans-diamminedichloroplatinum(II) on SV40 chromosomes: differential repair, DNA-protein crosslinking, and inhibition of replication

Ciccarelli, R. B., Solomon, M. J., Varshavsky, A. J., et al. (1985) · Biochemistry · doi:10.1021/bi00347a005 · Cited by 204 · see citing works

p53-dependent pathways of apoptosis

Benchimol, S. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400918 · Cited by 201 · see citing works

Caspase-3 is essential for procaspase-9 processing and cisplatin-induced apoptosis of MCF-7 breast cancer cells.

Blanc, C., Deveraux, Q. L., Krajewski, S., Jänicke, R. U., Porter, A. G., Reed, J. C., Jaggi, R. B., & Marti, A. (2000) · PubMed · Cited by 196 · see citing works

Functional interactions and signaling properties of mammalian DNA mismatch repair proteins

Bellacosa, A. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400948 · Cited by 188 · see citing works

p53 is a determinant of X-linked inhibitor of apoptosis protein/Akt-mediated chemoresistance in human ovarian cancer cells.

Fraser, M. E., Leung, B. M., Yan, X., Dan, H. C., Cheng, J. Q., & Tsang, B. K. (2003) · PubMed · Cited by 187 · see citing works

Enhanced replicative bypass of platinum-DNA adducts in cisplatin-resistant human ovarian carcinoma cell lines.

Mamenta, E. L., Poma, E., Kaufmann, W. K., Delmastro, D. A., Grady, H. L., & Chaney, S. G. (1994) · PubMed · Cited by 181 · see citing works

p53 and regulation of DNA damage recognition during nucleotide excision repair

Adimoolam, S., & Ford, J. M. (2003) · DNA Repair · doi:10.1016/s1568-7864(03)00087-9 · Cited by 181 · see citing works

Ixr1, a Yeast Protein That Binds to Platinated DNA and Confers Sensitivity to Cisplatin

Brown, S. J., Kellett, P. J., & Lippard, S. J. (1993) · Science · doi:10.1126/science.8342024 · Cited by 179 · see citing works

Inhibition of Extracellular Signal-regulated Protein Kinase or c-Jun N-terminal Protein Kinase Cascade, Differentially Activated by Cisplatin, Sensitizes Human Ovarian Cancer Cell Line

Hayakawa, J., Ohmichi, M., Kurachi, H., Ikegami, H., Kimura, A., Matsuoka, T., Jikihara, H., Mercola, D., & Murata, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.44.31648 · Cited by 175 · see citing works

Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental data

Tashiro, T., Kawada, Y., Sakurai, Y., & Kidani, Y. (1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90004-8 · Cited by 171 · see citing works

Msh2 status modulates both apoptosis and mutation frequency in the murine small intestine

Toft, N. J., Winton, D. J., Kelly, J., Howard, L., Dekker, M., Riele, H. T., Arends, M. J., Wyllie, A. H., Margison, G. P., & Clarke, A. R. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.7.3911 · Cited by 168 · see citing works

Conditional expression of mitogen-activated protein kinase phosphatase-1, MKP-1, is cytoprotective against UV-induced apoptosis

Franklin, C. C., Srikanth, S., & Kraft, A. S. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.6.3014 · Cited by 168 · see citing works

Effect of Glutathione on DNA Repair in Cisplatin-Resistant Human Ovarian Cancer Cell Lines

Lai, G., Ozols, R. F., Young, R. C., & Hamilton, T. C. (1989) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/81.7.535 · Cited by 167 · see citing works

Determination of cell fate by c-Abl activation in the response to DNA damage

Kharbanda, S. M., Yuan, Z.-M., Weichselbaum, R. W., & Kufe, D. W. (1998) · Oncogene · doi:10.1038/sj.onc.1202571 · Cited by 166 · see citing works

Role of the p38 MAPK pathway in cisplatin-based therapy

Hernández‐Losa, J., Cobo, C. P., Viniegra, J. G., Lobo, V. J. S.-A., y Cajal, S. R., & Sánchez‐Prieto, R. (2003) · Oncogene · doi:10.1038/sj.onc.1206608 · Cited by 165 · see citing works

Enhanced DNA repair and resistance to cisplatin in human ovarian cancer

Lai, G., Ozols, R. F., Smyth, J. F., Young, R. C., & Hamilton, T. C. (1988) · Biochemical Pharmacology · doi:10.1016/0006-2952(88)90325-5 · Cited by 156 · see citing works

Chemotherapy for advanced non-small-cell lung cancer: who, what, when, why?

Bunn, P. A. (2002) · PubMed · Cited by 153 · see citing works

Recognition and repair of DNA-cisplatin adducts.

Woźniak, K., & Błasiak, J. (2002) · Acta Biochimica Polonica · doi:10.18388/abp.2002_3768 · Cited by 152 · see citing works

Metabolic basis of the synergistic antitumor activities of 5-fluorouracil and cisplatin in rodent tumor models in vivo

Shirasaka, T., Shimamoto, Y., Ohshimo, H., et al. (1993) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00685830 · Cited by 151 · see citing works

p53-dependent and -independent responses to cisplatin in mouse testicular teratocarcinoma cells

Zamble, D. B., Jacks, T., & Lippard, S. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.11.6163 · Cited by 149 · see citing works

Antisense GADD45 expression results in decreased DNA repair and sensitizes cells to u.v.-irradiation or cisplatin.

Ml, S., Hu, K., Zhan, Q., Sreenath, A., O'Connor, P. M., & Fornace, A. J. (1996) · PubMed · Cited by 147 · see citing works

Copper‐transporting P‐type adenosine triphosphatase (ATP7B) as a cisplatin based chemoresistance marker in ovarian carcinoma: Comparative analysis with expression of MDR1, MRP1, MRP2, LRP and BCRP

Nakayama, K., Kanzaki, A., Ogawa, K., Miyazaki, K., Neamati, N., & Takebayashi, Y. (2002) · International Journal of Cancer · doi:10.1002/ijc.10608 · Cited by 145 · see citing works

Cisplatin and Related Anticancer Drugs: Recent Advances and Insights

Barnes, K. R., & Lippard, S. J. (2004) · CRC Press eBooks · doi:10.1201/b12414-5 · Cited by 145 · see citing works

Cross-linking of glutathione to DNA by cancer chemotherapeutic platinum coordination complexes

Eastman, A. R. (1987) · Chemico-Biological Interactions · doi:10.1016/0009-2797(87)90004-4 · Cited by 141 · see citing works

Negative Regulation of Mixed Lineage Kinase 3 by Protein Kinase B/AKT Leads to Cell Survival

Barthwal, M. K., Sathyanarayana, P., Kundu, C. N., Rana, B., Pradeep, A., Sharma, C., Woodgett, J. R., & Rana, A. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211598200 · Cited by 139 · see citing works

Evidence for Involvement of HMGB1 Protein in Human DNA Mismatch Repair

Yuan, F., Gu, L., Guo, S., Wang, C., & Li, G. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m401931200 · Cited by 138 · see citing works

c-Abl: activation and nuclear targets

Shaul, Y. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400626 · Cited by 138 · see citing works

Effect of DNA Polymerases and High Mobility Group Protein 1 on the Carrier Ligand Specificity for Translesion Synthesis past Platinum−DNA Adducts

Vaisman, A., Lim, S. E., Patrick, S. M., Copeland, W. C., Hinkle, D. C., Turchi, J. J., & Chaney, S. G. (1999) · Biochemistry · doi:10.1021/bi9909187 · Cited by 137 · see citing works

Association of Chromatin Proteins High Mobility Group Box (HMGB) 1 and HMGB2 with Mitotic Chromosomes

Pallier, C., Scaffidi, P., Chopineau-Proust, S., Agresti, A., Nordmann, P., Bianchi, M. E., & Maréchal, V. (2003) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-09-0581 · Cited by 137 · see citing works

Increase of the resistance of human cervical carcinoma cells to cisplatin by inhibition of the MEK to ERK signaling pathway partly via enhancement of anticancer drug-induced NFκB activation

Yeh, P.-Y., Chuang, S., Yeh, K., Song, Y., Ea, C.-K., & Cheng, A. (2002) · Biochemical Pharmacology · doi:10.1016/s0006-2952(02)00908-5 · Cited by 136 · see citing works

Involvement of the DNA mismatch repair system in antineoplastic drug resistance

Lage, H., & Dietel, M. (1999) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s004320050258 · Cited by 131 · see citing works

Abrogation of Mitochondrial Cytochrome c Release and Caspase-3 Activation in Acquired Multidrug Resistance

Kojima, H., Endo, K., Moriyama, H., Tanaka, Y., Alnemri, E. S., Slapak, C. A., Teicher, B. A., Kufe, D. W., & Datta, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.27.16647 · Cited by 131 · see citing works

Differential induction of c-Jun NH2-terminal kinase and c-Abl kinase in DNA mismatch repair-proficient and -deficient cells exposed to cisplatin.

Nehmé, A., Baskaran, R., Aebi, S. P., Fink, D. A., Nebel, S., Cenni, B., Wang, J. Y. J., Howell, S. B., & Christen, R. D. (1997) · PubMed · Cited by 129 · see citing works

CL100/MKP-1 modulates JNK activation and apoptosis in response to cisplatin

Sánchez‐Pérez, I., Martínez-Gomáriz, M., Williams, D. J., Keyse, S. M., & Perona, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203887 · Cited by 129 · see citing works

Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy.

Samimi, G., Fink, D. A., Varki, N. M., Husain, A., Hoskins, W. J., Alberts, D. S., & Howell, S. B. (2000) · PubMed · Cited by 128 · see citing works

Activation of p38 Mitogen-activated Protein Kinase by c-Abl-dependent and -independent Mechanisms

Pandey, P., Raingeaud, J., Kaneki, M., Weichselbaum, R. R., Davis, R. J., Kufe, D. W., & Kharbanda, S. M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.39.23775 · Cited by 128 · see citing works

Spontaneous development of drug resistance: mismatch repair and p53 defects in resistance to cisplatin in human tumor cells

Branch, P., Masson, M., Aquilina, G., Bignami, M., & Karran, P. (2000) · Oncogene · doi:10.1038/sj.onc.1203668 · Cited by 126 · see citing works

Current status of the development of trans-platinum antitumor drugs

Perez, J. M. T., Fuertes, M. A., Alonso‐Moreno, C., et al. (2000) · Critical Reviews in Oncology/Hematology · doi:10.1016/s1040-8428(00)00053-6 · Cited by 124 · see citing works

Chromatin and cell death

Bianchi, M. E., & Manfredi, A. A. (2003) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/j.bbaexp.2003.10.017 · Cited by 123 · see citing works

A Constitutive Active MEK → ERK Pathway Negatively Regulates NF-κB-dependent Gene Expression by Modulating TATA-binding Protein Phosphorylation

Carter, A. B., & Hunninghake, G. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m003599200 · Cited by 119 · see citing works

The RAG1 Homeodomain Recruits HMG1 and HMG2 To Facilitate Recombination Signal Sequence Binding and To Enhance the Intrinsic DNA-Bending Activity of RAG1-RAG2

Aidinis, V., Bonaldi, T., Beltrame, M., Santagata, S., Bianchi, M. E., & Spanopoulou, E. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.10.6532 · Cited by 117 · see citing works

Elevated DNA repair capacity is associated with intrinsic resistance of lung cancer to chemotherapy.

Zeng-Rong, N., Paterson, J., Alpert, L., et al. (1995) · PubMed · Cited by 116 · see citing works

Implication of p53 in base excision DNA repair: in vivo evidence

Seo, Y. R., Fishel, M. L., Amundson, S. A., Kelley, M. R., & Smith, M. L. (2002) · Oncogene · doi:10.1038/sj.onc.1205129 · Cited by 115 · see citing works

Prognostic Value of the Cu-Transporting ATPase in Ovarian Carcinoma Patients Receiving Cisplatin-Based Chemotherapy

Nakayama, K., Kanzaki, A., Terada, K., Mutoh, M., Ogawa, K., Sugiyama, T., Takenoshita, S., Itoh, K., Yaegashi, N., Miyazaki, K., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0454 · Cited by 114 · see citing works

Regulation of p73 by c-Abl through the p38 MAP kinase pathway

Sánchez‐Prieto, R., Lobo, V. J. S.-A., Servitja, J., & Gutkind, J. S. (2002) · Oncogene · doi:10.1038/sj.onc.1205134 · Cited by 113 · see citing works

Activation of the p53-dependent G1 checkpoint response in mouse embryo fibroblasts depends on the specific DNA damage inducer

Attardi, L. D., de Vries, A., & Jacks, T. (2004) · Oncogene · doi:10.1038/sj.onc.1207026 · Cited by 111 · see citing works

Effect of p53 Status on Sensitivity to Platinum Complexes in a Human Ovarian Cancer Cell Line

Pestell, K. E., Hobbs, S. M., Titley, J. C., Kèlland, L. R., & Walton, M. I. (2000) · Molecular Pharmacology · doi:10.1124/mol.57.3.503 · Cited by 111 · see citing works

Cisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcoma

Seki, K., Yoshikawa, H., Shiiki, K., et al. (2000) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s002800050030 · Cited by 107 · see citing works

Interaction with p53 Enhances Binding of Cisplatin-modified DNA by High Mobility Group 1 Protein

Imamura, T., Izumi, H., Nagatani, G., et al. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m008143200 · Cited by 106 · see citing works

Platinum drugs in the treatment of non-small-cell lung cancer

Cosaert, J. G. C. E., & Quoix, É. (2002) · British Journal of Cancer · doi:10.1038/sj.bjc.6600540 · Cited by 104 · see citing works

Nucleotide Excision Repair from Site-Specifically Platinum-Modified Nucleosomes

Wang, D., Hara, R., Singh, G., Sancar, A., & Lippard, S. J. (2003) · Biochemistry · doi:10.1021/bi034264k · Cited by 104 · see citing works

c-Abl Neutralizes the Inhibitory Effect of Mdm2 on p53

Sionov, R. V., Moallem, E., Berger, M., Kazaz, A., Gerlitz, O., Ben‐Neriah, Y., Oren, M., & Haupt, Y. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.13.8371 · Cited by 104 · see citing works

MutS Preferentially Recognizes Cisplatin- over Oxaliplatin-modified DNA

Zdraveski, Z. Z., Mello, J. A., Farinelli, C. K., Essigmann, J. M., & Marinus, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m105382200 · Cited by 103 · see citing works

The HMG-domain protein Ixr1 blocks excision repair of cisplatin-DNA adducts in yeast

McA'Nulty, M. M., & Lippard, S. J. (1996) · Mutation Research/DNA Repair · doi:10.1016/0921-8777(95)00037-2 · Cited by 102 · see citing works

Protein interactions with platinum–DNA adducts: from structure to function

Chaney, S. G., Campbell, S. L., Temple, B. R. S., Bassett, E., Wu, Y., & Faldu, M. (2004) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2004.04.024 · Cited by 97 · see citing works

Interaction of FACT, SSRP1, and the High Mobility Group (HMG) Domain of SSRP1 with DNA Damaged by the Anticancer Drug Cisplatin

YARNELL, A., Oh, S., Reinberg, D., & Lippard, S. J. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m101208200 · Cited by 96 · see citing works

The nuclear protein HMGB1, a new kind of chemokine?

Degryse, B., & de Virgilio, M. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)01027-5 · Cited by 96 · see citing works

Lack of c‐Jun activity increases survival to cisplatin

Sánchez‐Pérez, I., & Perona, R. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00690-0 · Cited by 95 · see citing works

Modulation of cis‐diamminedichloroplatinum(II) accumulation and sensitivity by forskolin and 3‐isobutyl‐1‐methylxanthine in sensitive and resistant human ovarian carcinoma cells

Mann, S. C., Andrews, P. A., & Howell, S. B. (1991) · International Journal of Cancer · doi:10.1002/ijc.2910480613 · Cited by 95 · see citing works

Binding of cis - and trans -dichlorodiammineplatinum(II) to the nucleosome core

Lippard, S. J., & Hoeschele, J. D. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.12.6091 · Cited by 92 · see citing works

Activation of MEK Kinase 1 by the c-Abl Protein Tyrosine Kinase in Response to DNA Damage

Kharbanda, S. M., Pandey, P., Yamauchi, T., Kumar, S., Kaneki, M., Kumar, V., Bharti, A. K., Yuan, Z.-M., Ghanem, L. R., Rana, A., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.14.4979-4989.2000 · Cited by 92 · see citing works

Kinetics and mechanism of uptake of platinum-based pharmaceuticals by the rat small intestine

Binks, S. P., & Dobrota, M. (1990) · Biochemical Pharmacology · doi:10.1016/0006-2952(90)90400-f · Cited by 91 · see citing works

Nucleotide-excision repair of DNA in cell-free extracts of the yeast Saccharomyces cerevisiae.

Wang, Z., Wu, X., & Friedberg, E. C. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.11.4907 · Cited by 89 · see citing works

Expression of copper-transporting P-type adenosine triphosphatase (ATP7B) as a chemoresistance marker in human oral squamous cell carcinoma treated with cisplatin

Miyashita, H., Nitta, Y., Mori, S., et al. (2003) · Oral Oncology · doi:10.1016/s1368-8375(02)00038-6 · Cited by 88 · see citing works

Modulation of p53 and p73 levels by cyclin G: implication of a negative feedback regulation

Ohtsuka, T., Ryu, H., Minamishima, Y. A., Ryo, A., & Lee, S. W. (2003) · Oncogene · doi:10.1038/sj.onc.1206306 · Cited by 84 · see citing works

BRCA1 Transcriptionally Regulates Damaged DNA Binding Protein (DDB2) In the DNA Repair Response Following UV-Irradiation

Takimoto, R., MacLachlan, T. K., Dicker, D. T., Niitsu, Y., Mori, T., & El‐Deiry, W. S. (2002) · Cancer Biology & Therapy · doi:10.4161/cbt.65 · Cited by 84 · see citing works

Estrogen-Derived Steroidal Metal Complexes: Agents for Cellular Delivery of Metal Centers to Estrogen Receptor-Positive Cells

Jackson, A. R., Davis, J., Pither, R. J., et al. (2001) · Inorganic Chemistry · doi:10.1021/ic010152a · Cited by 82 · see citing works

Testis-specific HMG-domain protein alters the responses of cells to cisplatin

Zamble, D. B., Mikata, Y., Eng, C. H., et al. (2002) · Journal of Inorganic Biochemistry · doi:10.1016/s0162-0134(02)00472-5 · Cited by 82 · see citing works

Molecular Determinants of the Cytotoxicity of Platinum Compounds

Vekris, A., Meynard, D., Haaz, M., Bayssas, M., Bonnet, J., & Robert, J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2258 · Cited by 82 · see citing works

Platinum Compounds in the Treatment of Advanced Breast Cancer

Martín, M. (2001) · Clinical Breast Cancer · doi:10.3816/cbc.2001.n.022 · Cited by 81 · see citing works

Cisplatin and its analogues in the treatment of advanced breast cancer: a review

Smith, I., & Talbot, D. C. (1992) · British Journal of Cancer · doi:10.1038/bjc.1992.169 · Cited by 75 · see citing works

Loss of DNA Mismatch Repair: Effects on the Rate of Mutation to Drug Resistance

Alas, M. M. D. L., Aebi, S. P., Fink, D. A., et al. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.20.1537 · Cited by 73 · see citing works

At the Crossroads of Necrosis and Apoptosis: Signaling to Multiple Cellular Targets by HMGB1

Bustin, M. (2002) · Science s STKE · doi:10.1126/stke.2002.151.pe39 · Cited by 72 · see citing works

Fine Structure and Activity of Discrete RAG-HMG Complexes on V(D)J Recombination Signals

Swanson, P. C. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.5.1340-1351.2002 · Cited by 72 · see citing works

Treatment of testicular germ-cell cancer: a cochrane evidence-based systematic review

Shelley, M. D., Burgon, K., & Mason, M. D. (2002) · Cancer Treatment Reviews · doi:10.1016/s0305-7372(02)00059-2 · Cited by 71 · see citing works

Cross-resistance to cisplatin in cells with acquired resistance to copper

Safaei, R., Katano, K., Samimi, G., et al. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0736-3 · Cited by 70 · see citing works

DNA repair is activated in early stages of p53-induced apoptosis

Geske, F. J., Nelson, A. C., Lieberman, R., Strange, R., Sun, T., & Gerschenson, L. E. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400663 · Cited by 69 · see citing works

The MEK1 inhibitor PD98059 sensitizes C8161 melanoma cells to cisplatin-induced apoptosis

Mandic, A., Viktorsson, K., Heiden, T., Hansson, J., & Shoshan, M. C. (2001) · Melanoma Research · doi:10.1097/00008390-200102000-00002 · Cited by 67 · see citing works

c-Abl-induced apoptosis, but not cell cycle arrest, requires mitogen-activated protein kinase kinase 6 activation

Cong, F., & Goff, S. P. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.24.13819 · Cited by 64 · see citing works

Decreased cisplatin uptake by resistant L1210 leukemia cells

Hromas, R., North, J. A., & Burns, C. P. (1987) · Cancer Letters · doi:10.1016/0304-3835(87)90091-7 · Cited by 64 · see citing works

Potential roles for p53 in nucleotide excision repair

McKay, B. C. (1999) · Carcinogenesis · doi:10.1093/carcin/20.8.1389 · Cited by 64 · see citing works

Transport of glutathione conjugates into secretory vesicles is mediated by the multidrug-resistance protein 1

van Luyn, M. J. A., Müller, M. M., Renes, J., Meijer, C., Scheper, R. J., Nienhuis, E. F., Mulder, N. H., Jansen, P. L. M., & de Vries, E. G. E. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980330)76:1 · Cited by 62 · see citing works

Transcriptional activation of the human HMG1 gene in cisplatin-resistant human cancer cells.

Nagatani, G., Nomoto, M., Takano, H., Ise, T., Kato, K., Imamura, T., Izumi, H., Makishima, K., & Kohno, K. (2001) · PubMed · Cited by 62 · see citing works

Cisplatin-induced Post-translational Modification of Histones H3 and H4

Wang, D., & Lippard, S. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402547200 · Cited by 60 · see citing works

Ultraviolet-sensitive syndrome cells are defective in transcription-coupled repair of cyclobutane pyrimidine dimers

Spivak, G., Itoh, T., Matsunaga, T., Nikaido, O., Hanawalt, P. C., & Yamaizumi, M. (2002) · DNA repair · doi:10.1016/s1568-7864(02)00056-3 · Cited by 59 · see citing works

High-throughput synthesis and screening of platinum drug candidates

Ziegler, C. J., Silverman, A. P., & Lippard, S. J. (2000) · JBIC Journal of Biological Inorganic Chemistry · doi:10.1007/s007750000170 · Cited by 57 · see citing works

Cisplatin inhibits chromatin remodeling, transcription factor binding, and transcription from the mouse mammary tumor virus promoter in vivo.

Mymryk, J. S., Zaniewski, E., & Archer, T. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.6.2076 · Cited by 56 · see citing works

Copper-transporting P-type adenosine triphosphatase (ATP7B) is expressed in human gastric carcinoma

Ohbu, M., Ogawa, K., 今野, 宗., et al. (2002) · Cancer Letters · doi:10.1016/s0304-3835(02)00462-7 · Cited by 56 · see citing works

Treatment of Advanced Non–Small-Cell Lung Cancer With Two-Drug Combinations

Bunn, P. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.20.17.3565 · Cited by 56 · see citing works

The interaction of cisplatin and analogues with DNA in reconstituted chromatin

Galea, A. M., & Murray, V. (2002) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(02)00535-3 · Cited by 55 · see citing works

Binding of A/T-rich DNA by Three High Mobility Group-like Domains in c-Abl Tyrosine Kinase

Miao, Y.-J., & Wang, J. Y. J. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.37.22823 · Cited by 55 · see citing works

Circadian Rhythms: Mechanisms and Therapeutic Implications

Levi, F., & Schibler, U. (2007) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105208 · Cited by 645 · see citing works

Small-molecule inhibition of Wee1 kinase by MK-1775 selectively sensitizes p53-deficient tumor cells to DNA-damaging agents

Hirai, H., Iwasawa, Y., Okada, M., Arai, T., Nishibata, T., Kobayashi, M., Kimura, T., Kaneko, N., Ohtani, J., Yamanaka, K., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0463 · Cited by 540 · see citing works

Hypoxia signaling in human health and diseases: implications and prospects for therapeutics

Luo, Z., Tian, M., Yang, G., Tan, Q., Chen, Y., Li, G., Zhang, Q., Li, Y., Wan, P., & Wu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01080-1 · Cited by 499 · see citing works

Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes

Hall, M. D., Telma, K. A., Chang, K.-E., Lee, T. D., Madigan, J. P., Lloyd, J. R., Goldlust, I. S., Hoeschele, J. D., & Gottesman, M. M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0247 · Cited by 377 · see citing works

ATR-Chk2 Signaling in p53 Activation and DNA Damage Response during Cisplatin-induced Apoptosis

Pabla, N., Huang, S., Mi, Q.-S., Daniel, R., & Dong, Z. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m707568200 · Cited by 309 · see citing works

Hexokinase-I Protection against Apoptotic Cell Death Is Mediated via Interaction with the Voltage-dependent Anion Channel-1

Abu-Hamad, S., Zaid, H., Israelson, A., Nahon, E., & Shoshan-Barmatz, V. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708216200 · Cited by 278 · see citing works

Autophagy Guards Against Cisplatin-Induced Acute Kidney Injury

Takahashi, A., Kimura, T., Takabatake, Y., Namba, T., Kaimori, J., Kitamura, H., Matsui, I., Niimura, F., Matsusaka, T., Fujita, N., et al. (2012) · The American Journal of Pathology · doi:10.1016/j.ajpath.2011.11.001 · Cited by 253 · see citing works

Metallodrugs in cancer nanomedicine

Peña, Q., Wang, A., Zaremba, O., Shi, Y., Scheeren, H. W., Metselaar, J. M., Kiessling, F., Pallares, R. M., Wuttke, S., & Lammers, T. (2022) · Chemical Society Reviews · doi:10.1039/d1cs00468a · Cited by 259 · see citing works

Functional interplay between ATM/ATR-mediated DNA damage response and DNA repair pathways in oxidative stress

Yan, S., Sorrell, M., & Berman, Z. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1666-4 · Cited by 247 · see citing works

hMSH2 Recruits ATR to DNA Damage Sites for Activation during DNA Damage-induced Apoptosis

Pabla, N., Ma, Z., McIlhatton, M. A., Fishel, R., & Dong, Z. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.210989 · Cited by 107 · see citing works

Fucoidan upregulates TLR4/CHOP-mediated caspase-3 and PARP activation to enhance cisplatin-induced cytotoxicity in human lung cancer cells

Hsu, H.-Y., Lin, T.-Y., Hu, C.-H., Shu, D. T. F., & Lu, M.-K. (2018) · Cancer Letters · doi:10.1016/j.canlet.2018.05.006 · Cited by 116 · see citing works

Molecular aspects of circadian pharmacology and relevance for cancer chronotherapy

Ozturk, N., Ozturk, D., Kavakli, I. H., & Okyar, A. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18102168 · Cited by 106 · see citing works

Cisplatin-Induced Renal Toxicity via Tumor Necrosis Factor-α, Interleukin 6, Tumor Suppressor P53, DNA Damage, Xanthine Oxidase, Histological Changes, Oxidative Stress and Nitric Oxide in Rats: Protective Effect of Ginseng

Yousef, M. I., & Hussien, H. M. (2015) · Food and Chemical Toxicology · doi:10.1016/j.fct.2015.01.014 · Cited by 104 · see citing works

PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells

Cheng, H., Zhang, Z., Borczuk, A., Powell, C. A., Balajee, A. S., Lieberman, H. B., & Halmos, B. (2013) · Carcinogenesis · doi:10.1093/carcin/bgs393 · Cited by 99 · see citing works

Coordinated regulation of XPA stability by ATR and HERC2 during nucleotide excision repair

Lee, T.-H., Park, J.-M., Leem, S.-H., & Kang, T.-H. (2014) · Oncogene · doi:10.1038/onc.2012.539 · Cited by 61 · see citing works

Targeting the Translesion Synthesis Pathway for the Development of Anti-Cancer Chemotherapeutics

Korzhnev, D. M., & Hadden, M. K. (2016) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.6b00596 · Cited by 58 · see citing works

MiR-182-5p protects inner ear hair cells from cisplatin-induced apoptosis by inhibiting FOXO3a

Li, Y., Li, A., Wu, J., He, Y., Yu, H., Chai, R., & Li, H. (2016) · Cell Death &amp; Disease · doi:10.1038/cddis.2016.246 · Cited by 46 · see citing works

Induction of targeted necrosis with HER2-targeted platinum( <scp>iv</scp> ) anticancer prodrugs

Wong, D. Y. Q., Lim, J. H., & Ang, W. H. (2015) · Chemical Science · doi:10.1039/c5sc00015g · Cited by 40 · see citing works

Enhancer-bound Nrf2 Licenses HIF-1α Transcription under Hypoxia to Promote Cisplatin Resistance in Hepatocellular Carcinoma Cells

Jin, X., Gong, L., Peng, Y., Li, L., & Liu, G. (2021) · Aging · doi:10.18632/aging.202137 · Cited by 24 · see citing works

Radiation-enhanced therapeutic targeting of galectin-1 enriched malignant stroma in triple negative breast cancer

Upreti, M., Jyoti, A., Johnson, S. E., Swindell, E. P., Napier, D., Sethi, P., Chan, R., Feddock, J. M., Weiss, H. L., O’Halloran, T. V., et al. (2106) · Oncotarget · doi:10.18632/oncotarget.9490 · Cited by 21 · see citing works

Early ageing after cytotoxic treatment for testicular cancer and cellular senescence: Time to act

Lubberts, S., Meijer, C., Demaria, M., & Gietema, J. A. (2020) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2020.102963 · Cited by 19 · see citing works

Data from Organic Cation Transporters Are Determinants of Oxaliplatin Cytotoxicity

Zhang, S., Lovejoy, K. S., Shima, J. E., et al. (2023) · doi:10.1158/0008-5472.c.6494126

Supplementary Tables 1 - 6 from Say No to DMSO: Dimethylsulfoxide Inactivates Cisplatin, Carboplatin, and Other Platinum Complexes

Hall, M. D., Telma, K. A., Chang, K.-E., et al. (2023) · doi:10.1158/0008-5472.22402952.v1

Supplementary Tables 1 - 6 from Say No to DMSO: Dimethylsulfoxide Inactivates Cisplatin, Carboplatin, and Other Platinum Complexes

Hall, M. D., Telma, K. A., Chang, K.-E., et al. (2023) · doi:10.1158/0008-5472.22402952

78 Pt Platinum‐Based Drugs

Brabec, V., & Kašpárková, J. (2005) · doi:10.1002/0470864052.ch25 · Cited by 10 · see citing works

Anti Cancer Activity of Platinum Complexes

Shiju, C. (2011)